Harmony Biosciences Holdings, Inc. · NASDAQ:HRMY
Zaeske Adam H. exercised options for 7,500 Harmony Biosciences Holdings, Inc. shares (Form 4)
Traded Apr 7, 2026 · Filed Apr 9, 2026
On Apr 7, 2026, Zaeske Adam H. (CHIEF COMMERCIAL OFFICER) exercised options for 7,500 Harmony Biosciences Holdings, Inc. shares, leaving 4,327 shares. Filed Apr 9, 2026 (Form 4).
- Options exercised
- 7,500 shares
- Holding after
- 4,327 shares
- Trading plan
- No
- Role
- CHIEF COMMERCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 7, 2026 | Common Stock | Option exercise | 7,500 | 7,500 | Direct | |
| Apr 7, 2026 | Common Stock | Shares withheld for tax | 3,173 | US$27.62 | 4,327 | Direct |
Source
Related
- Harmony Biosciences Holdings, Inc.
- Zaeske Adam H.
- Harmony Biosciences Holdings, Inc. shareholders
- Form 4 · Budur Kumar · Sep 18, 2026
- Form 4 · Budur Kumar · Sep 9, 2026
- Schedule 13G · Vanguard Portfolio Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Budur Kumar · May 18, 2026